References
- American Diabetes Association, (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care, 34(Suppl 1), S62–S69.
- Bakala, H., Hamelin, M., Mary, J., Borot-Laloi, C., & Friguet, B. (2012). Catalase, a target of glycation damage in rat liver mitochondria with aging. Biochimica et Biophysica Acta, 8, 1527–1534.10.1016/j.bbadis.2012.05.016
- De Berardis, G., Sacco, M., Strippoli, G. F., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009). Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-analysis of randomized controlled trials. British Medical Journal, 339, b4531.10.1136/bmj.b4531
- Góth, L., & Nagy, T. (2013). Inherited catalase deficiency: Is it benign or a factor in various age related disorders? Mutation Research, 753, 147–154.10.1016/j.mrrev.2013.08.002
- Harding, J. J., & Ganea, E. (2006). Protection against glycation and similar post-translational modifications of proteins. Biochimica et Biophysica Acta, 1764, 1436–1446.10.1016/j.bbapap.2006.08.001
- Huijberts, M. S., Schaper, N. C., & Schalkwijk, C. G. (2008). Advanced glycation end products and diabetic foot disease. Diabetes/Metabolism Research and Reviews, 24,(S1) S19–S24.10.1002/(ISSN)1520-7560
- Koohshekan, B., Divsalar, A., Saiedifar, M., Saboury, A. A., Ghalandari, B., Gholamian, A., & Seyedarabi, A. (2016). Protective effects of aspirin on the function of bovine liver catalase: A spectroscopy and molecular docking study. Journal of Molecular Liquids, 218, 5–18.
- Lin, J. (1996). The association between copper ions and peroxidative reaction in diabetic cataract. Nippon Ganka Gakkai Zasshi, 100, 672–679.
- Ookawara, T., Kawamura, N., Kitagawa, Y., & Taniguchi, N. (1992). Site-specific and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. Journal of Biological Chemistry, 267, 18505–18510.
- Qin, P., & Liu, R. (2013). Oxidative stress response of two fluoroquinolones with catalase and erythrocytes: A combined molecular and cellular study. Journal of Hazardous Materials, 252–253, 321–329.10.1016/j.jhazmat.2013.03.006
- Sharma, R. N., & Pancholi, S. S. (2014). Protein binding interaction study of olmesartan medoxomil and its metabolite olmesartan by fluorescence spectroscopy. International Journal of Pharmacy and Pharmaceutical Sciences, 6 (Suppl. 2), 726–729.
- Wang, R., Zhang, L., Wang, R., Dou, H., Li, H., Wang, Y., & Wang, R. (2013). Spectroscopic study on the interaction of catalase with bifendate and analogs. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 102, 88–98.10.1016/j.saa.2012.10.039
- Xu, Q., Lu, Y., Jing, L., Cai, L., Zhu, X., Xie, J., & Hu, X. (2014). Specific binding and inhibition of 6-benzylaminopurine to catalase: Multiple spectroscopic methods combined with molecular docking study. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 123, 327–335.10.1016/j.saa.2013.12.021
- Yang, B., Hao, F., Li, J., Chen, D., & Liu, R. (2013). Binding of chrysoidine to catalase: Spectroscopy, isothermal titration calorimetry and molecular docking studies. Journal of Photochemistry and Photobiology B: Biology, 128, 35–42.10.1016/j.jphotobiol.2013.08.006
- Zhaozhen, C., Rutao, L., & Bingjun, Y. (2013). Potential toxicity of sarafloxacin to catalase: Spectroscopic, ITC and molecular docking descriptions. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 115, 457–463.